G2 checkpoint abrogation and checkpoint kinase-1 targeting in the treatment of cancer von Bucher, N, Britten, C D

Volltext

Phase I and Pharmacologic Study of OSI-774, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Advanced Solid Malignancies von HIDALGO, Manuel, SIU, Lillian L, FERRANTE, Karen, VON HOFF, Daniel D, SILBERMAN, Sandra, ROWINSKY, Eric K, NEMUNAITIS, John, RIZZO, Jinee, HAMMOND, Lisa A, TAKIMOTO, Chris, ECKHARDT, S. Gail, TOLCHER, Anthony, BRITTEN, Carolyn D, DENIS, Louis

Volltext

Enhanced antitumor activity of 6-hydroxymethylacylfulvene in combination with irinotecan and 5-fluorouracil in the HT29 human colon tumor xenograft model von BRITTEN, C. D, HILSENBECK, S. G, ECKHARDT, S. G, MARTY, J, MANGOLD, G, MACDONALD, J. R, ROWINSKY, E. K, VON HOFF, D. D, WEITMAN, S

Volltext

Phase I/IIa trial of the mammalian target of rapamycin inhibitor ridaforolimus (AP23573; MK-8669) administered orally in patients with refractory or advanced malignancies and sarco... von Mita, M.M., Poplin, E., Britten, C.D., Tap, W.D., Rubin, E.H., Scott, B.B., Berk, L., Rivera, V.M., Loewy, J.W., Dodion, P., Haluska, F., Sarantopoulos, J., Mita, A., Tolcher, A.

Volltext

A Phase I and Pharmacological Study of the Farnesyl Protein Transferase Inhibitor L-778,123 in Patients with Solid Malignancies von BRITTEN, Carolyn D, ROWINSKY, Eric K, PEZZULI, Sandy, SPRIGGS, David, SOIGNET, Steven, PATNAIK, Amita, YAO, Siu-Long, DEUTSCH, Paul, YIH LEE, LOBELL, Robert B, MAZINA, Kathryn E, MCCREERY, Heather

Volltext

Oral Paclitaxel and Concurrent Cyclosporin A: Targeting Clinically Relevant Systemic Exposure to Paclitaxel von BRITTEN, Carolyn D, BAKER, Sharyn D, DENIS, Louis J, JOHNSON, Thomas, DRENGLER, Ronald, SIU, Lillian L, DUCHIN, Ken, KUHN, John, ROWINSKY, Eric K

Volltext

Activity of the multitargeted antifolate LY231514 in the human tumor cloning assay von BRITTEN, C. D, IZBICKA, E, HILSENBECK, S, LAWRENCE, R, DAVIDSON, K, CERNA, C, GOMEZ, L, ROWINSKY, E. K, WEITMAN, S, VON HOFF, D. D

Volltext

A Phase I and Pharmacokinetic Study of the Mitochondrial-specific Rhodacyanine Dye Analog MKT 077 von BRITTEN, C. D, ROWINSKY, E. K, VON HOFF, D. D, ECKHARDT, S. G, BAKER, S. D, WEISS, G. R, SMITH, L, STEPHENSON, J, ROTHENBERG, M, SMETZER, L, CRAMER, J, COLLINS, W

Volltext

A Phase I and Pharmacokinetic Study of Temozolomide and Cisplatin in Patients with Advanced Solid Malignancies von BRITTEN, C. D, ROWINSKY, E. K, FRAASS, U, STATKEVICH, P, VON HOFF, D. D, ECKHARDT, S. G, BAKER, S. D, AGARWALA, S. S, ECKARDT, J. R, BARRINGTON, R, DIAB, S. G, HAMMOND, L. A, JOHNSON, T, VILLALONA-CALERO, M

Volltext

Phase I and Pharmacokinetic Study of BMS-184476, a Taxane With Greater Potency and Solubility Than Paclitaxel von HIDALGO, Manuel, AYLESWORTH, Cheryl, FELTON, Sally, GUPTA, Elora, FERRANTE, Karen J, TORTORA, Anne, SONNICHSEN, Daryl S, SKILLINGS, Jamey, ROWINSKY, Eric K, HAMMOND, Lisa A, BRITTEN, Carolyn D, WEISS, Geoffrey, STEPHENSON, Joseph JR, SCHWARTZ, Garry, PATNAIK, Amita, SMITH, Lon, MOLPUS, Kathleen

Volltext

Phase I and pharmacokinetic (PK) Study of CP-724,714, an oral human epidermal growth factor receptor-2 (HER-2) selective tyrosine kinase inhibitor von Munster, P. N., Mita, M., Britten, C., Minton, S., Moulder, S., Noe, D., Roedig, B., Denis, L., Slamon, D., Tolcher, A.

Volltext

Phase I and pharmacokinetic (PK) Study of CP-724,714, an oral human epidermal growth factor receptor-2 (HER-2) selective tyrosine kinase inhibitor von Munster, P. N., Mita, M., Britten, C., Minton, S., Moulder, S., Noe, D., Roedig, B., Denis, L., Slamon, D., Tolcher, A.

Volltext

Danger or Shelter? Lullabies in the Music of Benjamin Britten von Leccia, Marinu

Volltext

Redox Signaling and Bioenergetics Influence Lung Cancer Cell Line Sensitivity to the Isoflavone ME-344 von Manevich, Yefim, Reyes, Leticia, Britten, Carolyn D, Townsend, Danyelle M, Tew, Kenneth D

Volltext

First-in-human study of the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of PF-00299804, a small molecule irreversible panHER inhibitor in patients with a... von Schellens, J. H., Britten, C. D., Camidge, D. R., Boss, D., Wong, S., Diab, S., Guo, F., Maguire, R. P., Letrent, S. P., Eckhardt, S. G.

Volltext

Using cold-stored or overwintering Aceria malherbae Nuzzaci (Acarina: Eriophyiidae), a gall-forming eriophyiid mite, for infestation of field bindweed von Britten, D. C, Schuster, G. L, Michels, G. J. Jr, Owings, D. A

Volltext

A musician for an occasion »: Britten, compositeur engagé von Couderc, Gilles

Volltext

G2 checkpoint abrogation and checkpoint kinase-I targeting in the treatment of cancer von BUCHER, N, BRITTEN, C. D

Volltext

Pharmacokinetics of oral deforolimus (AP23573, MK-8669) von Fetterly, G. J., Mita, M. M., Britten, C. D., Poplin, E., Tap, W. D., Carmona, A., Yonemoto, L., Bedrosian, C. L., Rubin, E. H., Tolcher, A. W.

Volltext

Rising Stars. Cristina Gómez-Godoy - Mario Häring - Britten, Debussy, Kalliwoda, Bray von Johann Wenzel Kalliwoda, Benjamin Britten, Claude Debussy, Charlotte Bray

Volltext bestellen